Crossmark

Impact of FDA-Required Cardiovascular Outcome Trials on Type 2 Diabetes Clinical Study Initiation From 2008 to 2017

Crossref DOI link: https://doi.org/10.1007/s43441-019-00098-y

Published Online: 2020-01-06

Published Print: 2020-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kieffer, Cameron M. https://orcid.org/0000-0001-7509-7503
Robertson, Andrew S. https://orcid.org/0000-0003-2568-5379
License Information

Text and Data Mining valid from 2020-01-06
More Information

Article History

Received: 22 April 2019

Accepted: 6 June 2019

First Online: 6 January 2020